GlassScriptPhysician profile
Rahul Laroia
NPI 1689647695
$3,102.30
in general payments reported to CMS, 2019-2025
25 companies · $664 in 2025
The $664 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $401 · 2020: $218 · 2021: $136 · 2022: $589 · 2023: $705 · 2024: $389 · 2025: $664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,731 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,730.61 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $399.80 | 2019-2025 | |
| Astellas Pharma US INC | $359.04 | 2019-2024 | Veozah, Myrbetriq |
| Abbvie INC. | $339.33 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $250.03 | 2023-2025 | Myfembree, Gemtesa |
| Caldera Medical, INC | $201.17 | 2021-2023 | Desara |
| Exeltis, USA INC. | $193.46 | 2023-2025 | Slynd |
| Valencia Technologies Corporation | $188.74 | 2025 | Ecoin Device Kit |
| Boston Scientific Corporation | $180.30 | 2020-2025 | General - Female Sui |
| Allergan, INC. | $132.62 | 2019-2020 | |
| Amgen INC. | $118.89 | 2022 | |
| Myovant Sciences INC. | $101.69 | 2022 | |
| Mayne Pharma Commercial LLC | $99.84 | 2022-2024 | |
| Coloplast Corp | $78.80 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $72.49 | 2020-2023 | |
| Coopersurgical, INC. | $62.81 | 2019-2024 | Paragard T 380a |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $53.75 | 2020-2025 | Omni Hysteroscope, Myosure Tissue Removal Device |
| Lupin INC. | $43.69 | 2019-2020 | |
| Laborie Medical Technologies Corp. | $43.62 | 2021 | |
| Dentsply Ih Ab | $37.16 | 2025 | Lofric |
| Ge Healthcare | $34.55 | 2020 | |
| Biogen, INC. | $28.72 | 2025 | Zurzuvae |
| Millicent US INC | $26.70 | 2024 | |
| Organon LLC | $24.89 | 2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $16.08 | 2024 | Gardasil, Gardasil 9 |
| Amag Pharmaceuticals, INC. | $14.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rahul Laroia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.